Dr. Atreya Dash joined the Department of Urology at the University of Washington in August 2013. He completed a three-year fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center in New York, having previously completed his urology training at the University of Michigan.
Patient Care Philosophy
It is a privilege for me to be involved in a patient’s cancer care. I believe that quality cancer care is important, but it needs to be delivered in the context of the patient’s overall health and goals. To me, gaining or maintaining quality of life is as important as gaining quantity of life.
Dr. Dash has experience in all areas of urologic oncology such as the surgical treatment of prostate, renal, testis and bladder cancers with the use of continent urinary diversion for reconstruction after cystectomy. He uses the da Vinci robotic system to perform laparoscopic operations, including radical prostatectomy, radical cystecomy and partial nephrectomy.
Dr. Dash’s clinical research has focused on prostate, bladder, kidney and testis cancers. His laboratory research has focused on molecular aspects of prostate and bladder cancer including application of microarray technology. His clinical and laboratory research have been published in peer reviewed publications.
|University of California, Irvine||Teaching Appointment|
|University of Vermont College of Medicine||Medical education||1998|
|University of Michigan Health System||Internship|
|University of Michigan||Residency|
|Memorial Sloan-Kettering Cancer Center||Fellowship|
|MD||University of Vermont College of Medicine||1998|
|American Board of Urology||Urology||2009|